Author:
Dannecker Günther,Hospach Toni
Publisher
Springer Berlin Heidelberg
Reference111 articles.
1. Athappan G, Gale S, Ponniah T (2009) Corticosteroid therapy for primary treatment of Kawasaki disease – weight of evidence: a meta-analysis and systematic review of the literature. Cardiovasc J Afr 20:233–236
2. Ballester J, Borràs S, Curcoll R, Navarro-Gallinad A, Pozdniakova S, Cañas L, Burns JC, Rodó X (2019) On the interpretation of the atmospheric mechanism transporting the environmental trigger of Kawasaki disease. PLoS One 14:e0226402
3. Baumer JH, Love SJL, Gupta A, Haines LC, Maconochie I, Dua JS (2006) Salicylate for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev:CD004175
4. Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RSM (2005) Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 116:e760–e766
5. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17:1144–1148